Literature DB >> 29569975

Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials<sup/>.

Laura Gengenbach1, Heike Reinhardt1, Gabriele Ihorst2, Stefanie Ajayi1,3, Sandra Maria Dold1, Martin Köhler1, Hermann Einsele4, Justus Duyster1,3, Ralph Wäsch1,3, Monika Engelhardt1,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29569975     DOI： 10.1080/10428194.2018.1448084

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

1.  Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma).

Authors:  Johannes M Waldschmidt; Alexander Keller; Gabriele Ihorst; Olga Grishina; Stefan Müller; Dagmar Wider; Anna V Frey; Kristina King; Roman Simon; Annette May; Pierfrancesco Tassone; Justus Duyster; Manfred Jung; Noopur Raje; Ralph Wäsch; Monika Engelhardt
Journal:  Haematologica       Date:  2018-04-19       Impact factor: 9.941

2.  Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.

Authors:  Monika Engelhardt; Gabriele Ihorst; Martin Schumacher; Michael Rassner; Laura Gengenbach; Mandy Möller; Khalid Shoumariyeh; Jakob Neubauer; Juliane Farthmann; Georg Herget; Ralph Wäsch
Journal:  BMC Cancer       Date:  2021-02-17       Impact factor: 4.430

3.  Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany.

Authors: 
Journal:  Haematologica       Date:  2020-07-30       Impact factor: 9.941

4.  Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan.

Authors:  Yanfang Liu; Chao-Hsiun Tang; Hong Qiu; Sarah Siggins; Hsin-An Hou
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

5.  Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France - a cohort study using the French National Healthcare database (SNDS).

Authors:  Cyrille Touzeau; Nadia Quignot; Jie Meng; Heng Jiang; Artak Khachatryan; Moushmi Singh; Vanessa Taieb; Jean-Vannak Chauny; Gaëlle Désaméricq
Journal:  Ann Hematol       Date:  2021-04-21       Impact factor: 3.673

6.  Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age.

Authors:  Monika Engelhardt; Gabriele Ihorst; Jesus Duque-Afonso; Ulrich Wedding; Ernst Spät-Schwalbe; Valentin Goede; Gerald Kolb; Reinhard Stauder; Ralph Wäsch
Journal:  Haematologica       Date:  2020-04-02       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.